Pharmafile Logo

VJOncology

National Institute for Health and Care Excellence NICE logo

NICE consults on value-based assessment changes

Aims to create a more flexible approach to drug funding decisions for NHS in England and Wales

- PMLiVE

Final NICE backing for MabThera in rare condition

Roche drug available in England and Wales to treat rare form of vasculitis

- PMLiVE

EMA clears GSK’s diabetes therapy Eperzan

Once-weekly GLP-1 therapy will line-up against Victoza and Byetta

- PMLiVE

Merck KGaA loses global head of R&D

Senior reshuffle also sees departure of head of Merck Millipore

- PMLiVE

EFPIA hires director of European affairs

Elizabeth Kuiper will join trade body on May 1

- PMLiVE

AstraZeneca launches delivery service for Nexium

Expands its US direct-to-patient programme

- PMLiVE

Let’s rock the system

Marketing is about influencing the decisions your audiences make. But to get there, you may need to change your habits of a lifetime

- PMLiVE

GSK withdraws melanoma combo in EU

EMA says it needs more data to review Mekinist and Tafinlar

Novartis building

More bad news for Novartis on heart failure candidate

FDA reviewers recommend against approving serelaxin

- PMLiVE

Pfizer says Xalkori tops chemo as first line therapy

Superior progression free survival for lung cancer patients

- PMLiVE

M3 recruits Google’s former industry head of healthcare

Jenny Cowderoy joins online group's newly-expanded European operations

Novartis day

Novartis’ German poster campaign to raise vaccination awareness

In-house designed work aims to educate public about meningococcal bacteria

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links